Agonistic and antagonistic activities of chemokines
Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic a...
Gespeichert in:
Veröffentlicht in: | Journal of leukocyte biology 2001-06, Vol.69 (6), p.881-884 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 884 |
---|---|
container_issue | 6 |
container_start_page | 881 |
container_title | Journal of leukocyte biology |
container_volume | 69 |
creator | Loetscher, Pius Clark‐Lewis, Ian |
description | Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects. |
doi_str_mv | 10.1189/jlb.69.6.881 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17908109</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17908109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqWwMaMuMJHgsxN_jKXiU5VYYLZS-9K6JE2JU6L-e4JS0Y3hdNLpufeVHkIugcYASt-tinksdCxipeCIDEFzFXEh-TEZUplAlCaUDshZCCtKKWeCnpIBQEITLmFI-GRRrX1ovB1na9dNkx0OtvHfvvEYxlU-tkssq0-_xnBOTvKsCHix3yPy8fjwPn2OZm9PL9PJLLJcS4iUS51i3OkUOUvA0rlTqUKu81Tm3KaopWTIBXeKAmqKzNlccsnShGXCSj4iN33upq6-thgaU_pgsSiyNVbbYEBqqoDqDrztQVtXIdSYm03ty6zeGaDmV5LpJBmhjTCdpA6_2udu5yW6A7y30gHQA60vcPdvmHmd3dM-9Lr_WfrFsvU1mlBmRdFVMNO27V_5D7szfgU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17908109</pqid></control><display><type>article</type><title>Agonistic and antagonistic activities of chemokines</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Loetscher, Pius ; Clark‐Lewis, Ian</creator><creatorcontrib>Loetscher, Pius ; Clark‐Lewis, Ian</creatorcontrib><description>Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.</description><identifier>ISSN: 0741-5400</identifier><identifier>EISSN: 1938-3673</identifier><identifier>DOI: 10.1189/jlb.69.6.881</identifier><identifier>PMID: 11404371</identifier><language>eng</language><publisher>United States: Society for Leukocyte Biology</publisher><subject>Amino Acid Motifs ; chemokine receptors ; Chemokines - chemistry ; Chemokines - pharmacology ; Chemokines - physiology ; chemotaxis ; Chemotaxis, Leukocyte - drug effects ; Chemotaxis, Leukocyte - physiology ; GTP-Binding Proteins - physiology ; guanine nucleotide-binding protein ; Humans ; inflammation ; Leukocytes - cytology ; Leukocytes - drug effects ; Models, Biological ; natural antagonists ; Protein Binding ; Protein Structure, Tertiary ; Receptors, Chemokine - agonists ; Receptors, Chemokine - antagonists & inhibitors ; Receptors, Chemokine - chemistry ; Receptors, Chemokine - physiology ; Structure-Activity Relationship</subject><ispartof>Journal of leukocyte biology, 2001-06, Vol.69 (6), p.881-884</ispartof><rights>2001 Society for Leukocyte Biology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</citedby><cites>FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1189%2Fjlb.69.6.881$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1189%2Fjlb.69.6.881$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11404371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Loetscher, Pius</creatorcontrib><creatorcontrib>Clark‐Lewis, Ian</creatorcontrib><title>Agonistic and antagonistic activities of chemokines</title><title>Journal of leukocyte biology</title><addtitle>J Leukoc Biol</addtitle><description>Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.</description><subject>Amino Acid Motifs</subject><subject>chemokine receptors</subject><subject>Chemokines - chemistry</subject><subject>Chemokines - pharmacology</subject><subject>Chemokines - physiology</subject><subject>chemotaxis</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Chemotaxis, Leukocyte - physiology</subject><subject>GTP-Binding Proteins - physiology</subject><subject>guanine nucleotide-binding protein</subject><subject>Humans</subject><subject>inflammation</subject><subject>Leukocytes - cytology</subject><subject>Leukocytes - drug effects</subject><subject>Models, Biological</subject><subject>natural antagonists</subject><subject>Protein Binding</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, Chemokine - agonists</subject><subject>Receptors, Chemokine - antagonists & inhibitors</subject><subject>Receptors, Chemokine - chemistry</subject><subject>Receptors, Chemokine - physiology</subject><subject>Structure-Activity Relationship</subject><issn>0741-5400</issn><issn>1938-3673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQhi0EoqWwMaMuMJHgsxN_jKXiU5VYYLZS-9K6JE2JU6L-e4JS0Y3hdNLpufeVHkIugcYASt-tinksdCxipeCIDEFzFXEh-TEZUplAlCaUDshZCCtKKWeCnpIBQEITLmFI-GRRrX1ovB1na9dNkx0OtvHfvvEYxlU-tkssq0-_xnBOTvKsCHix3yPy8fjwPn2OZm9PL9PJLLJcS4iUS51i3OkUOUvA0rlTqUKu81Tm3KaopWTIBXeKAmqKzNlccsnShGXCSj4iN33upq6-thgaU_pgsSiyNVbbYEBqqoDqDrztQVtXIdSYm03ty6zeGaDmV5LpJBmhjTCdpA6_2udu5yW6A7y30gHQA60vcPdvmHmd3dM-9Lr_WfrFsvU1mlBmRdFVMNO27V_5D7szfgU</recordid><startdate>200106</startdate><enddate>200106</enddate><creator>Loetscher, Pius</creator><creator>Clark‐Lewis, Ian</creator><general>Society for Leukocyte Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200106</creationdate><title>Agonistic and antagonistic activities of chemokines</title><author>Loetscher, Pius ; Clark‐Lewis, Ian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3971-8d5d823d95e3241c0bd858e39f57f3c5e9772e363d801e90e2dcf7372542a6c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amino Acid Motifs</topic><topic>chemokine receptors</topic><topic>Chemokines - chemistry</topic><topic>Chemokines - pharmacology</topic><topic>Chemokines - physiology</topic><topic>chemotaxis</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Chemotaxis, Leukocyte - physiology</topic><topic>GTP-Binding Proteins - physiology</topic><topic>guanine nucleotide-binding protein</topic><topic>Humans</topic><topic>inflammation</topic><topic>Leukocytes - cytology</topic><topic>Leukocytes - drug effects</topic><topic>Models, Biological</topic><topic>natural antagonists</topic><topic>Protein Binding</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, Chemokine - agonists</topic><topic>Receptors, Chemokine - antagonists & inhibitors</topic><topic>Receptors, Chemokine - chemistry</topic><topic>Receptors, Chemokine - physiology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Loetscher, Pius</creatorcontrib><creatorcontrib>Clark‐Lewis, Ian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of leukocyte biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Loetscher, Pius</au><au>Clark‐Lewis, Ian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Agonistic and antagonistic activities of chemokines</atitle><jtitle>Journal of leukocyte biology</jtitle><addtitle>J Leukoc Biol</addtitle><date>2001-06</date><risdate>2001</risdate><volume>69</volume><issue>6</issue><spage>881</spage><epage>884</epage><pages>881-884</pages><issn>0741-5400</issn><eissn>1938-3673</eissn><abstract>Since the discovery of interleukin‐8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte—lymphocytes in particular. All chemokines act via seven‐transmembrane domain, G protein‐coupled receptors. Eighteen such receptors have been identified so far. Studies on structure‐activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2‐terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2‐terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2‐terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.</abstract><cop>United States</cop><pub>Society for Leukocyte Biology</pub><pmid>11404371</pmid><doi>10.1189/jlb.69.6.881</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5400 |
ispartof | Journal of leukocyte biology, 2001-06, Vol.69 (6), p.881-884 |
issn | 0741-5400 1938-3673 |
language | eng |
recordid | cdi_proquest_miscellaneous_17908109 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Amino Acid Motifs chemokine receptors Chemokines - chemistry Chemokines - pharmacology Chemokines - physiology chemotaxis Chemotaxis, Leukocyte - drug effects Chemotaxis, Leukocyte - physiology GTP-Binding Proteins - physiology guanine nucleotide-binding protein Humans inflammation Leukocytes - cytology Leukocytes - drug effects Models, Biological natural antagonists Protein Binding Protein Structure, Tertiary Receptors, Chemokine - agonists Receptors, Chemokine - antagonists & inhibitors Receptors, Chemokine - chemistry Receptors, Chemokine - physiology Structure-Activity Relationship |
title | Agonistic and antagonistic activities of chemokines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A52%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Agonistic%20and%20antagonistic%20activities%20of%20chemokines&rft.jtitle=Journal%20of%20leukocyte%20biology&rft.au=Loetscher,%20Pius&rft.date=2001-06&rft.volume=69&rft.issue=6&rft.spage=881&rft.epage=884&rft.pages=881-884&rft.issn=0741-5400&rft.eissn=1938-3673&rft_id=info:doi/10.1189/jlb.69.6.881&rft_dat=%3Cproquest_cross%3E17908109%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17908109&rft_id=info:pmid/11404371&rfr_iscdi=true |